Cytokines are soluble proteins that allow for communication between cells and the external environment.Interferon (IFN) a, the first cytokine to be produced by recombinant DNA technology, has emerged as an important regulator ofgrowth and differentiation, affecting cellular communication and signal transduction pathways as well as immunological control. This review focuses on the biological and clinical activities of the cytokine. Originally discovered as an antiviral substance, the efficacy of IFN-a in malignant, viral, immunological, angiogenic, inflammatory, and fibrotic diseases suggests a spectrum of interrelated pathophysiologies. The principles learned from in vivo studies will be discussed, particulady hairy cell leukemia, chronic myelogenous leukemia, certain angiogenic diseases, and hepatitis. After the surprising discovery of activity in a rare B-cell neoplasm, IFN-a emerged as a prototypic tumor suppressor protein that represses the dinhl tumorigenic phenotype in some malgancies capable of differentiation. Regulatory agencies throughout the world have approved IFN-a for treatment of 13